LivaNova PLC (LIVN) vs Regencell Bioscience Holdings Limited (RGC)

A side-by-side comparison of LivaNova PLC and Regencell Bioscience Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
LivaNova PLC logo
LIVN
LivaNova PLC
$4.12B
$74.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Regencell Bioscience Holdings Limited logo
RGC
Regencell Bioscience Holdings Limited
$3.64B
$7.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — LIVN vs RGC

growth of $100 · dividends reinvested · last 5y
LIVN -3.1% (-0.6%/yr)RGC +2520.2% (+92.2%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
101001k10k100kStart $10020222023202420252026$97$2,620
LIVN RGC

LIVN vs RGC: by the numbers

  • •LIVN is the larger company ($4.12B vs $3.64B market cap).
  • •LIVN is profitable (12.82% net margin) while RGC runs a net loss (0.00%).

Metrics side by side

Valuation

MetricLIVNRGC
P/E ratio22.10N/A
Forward P/E17.20N/A
P/S ratio2.80N/A
P/B ratio3.112986.54
EV / EBITDA16.17N/A
FCF yield3.60%N/A

Profitability

MetricLIVNRGC
Gross margin68.18%0.00%
Operating margin13.48%0.00%
Net margin12.82%0.00%
ROE14.23%-73.75%
ROIC10.24%-69.75%

Growth (annualized)

MetricLIVNRGC
Revenue CAGR (5Y)7.57%N/A
FCF CAGR (5Y)20.23%N/A
Total return CAGR (5Y)-1.66%67.94%

Frequently asked

Is LIVN or RGC more profitable?
LIVN runs the higher net margin — LIVN at 12.82% versus RGC at 0.00%.
How have LIVN and RGC total returns compared?
Over the past 5 years, LIVN delivered -1.66% and RGC delivered 67.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LIVN analysisFull RGC analysisInteractive comparison tool

Dig into the metrics

LivaNova P/E ratioLivaNova ROERegencell Bioscience ROELivaNova operating marginRegencell Bioscience operating marginLivaNova revenue growthRegencell Bioscience revenue growthLivaNova free cash flowRegencell Bioscience free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.